These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 19319530)

  • 21. HLA-G as a target molecule in specific immunotherapy against renal cell carcinoma.
    Komohara Y; Harada M; Ishihara Y; Suekane S; Noguchi M; Yamada A; Matsuoka K; Itoh K
    Oncol Rep; 2007 Dec; 18(6):1463-8. PubMed ID: 17982631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of MG7-Ag in patients with gastric cancer correlates with weaker T cell immune response and more proinflammatory cytokine secretion.
    Zhang X; Hong L; Chan WY; Qiao T; Chen B; Liu Y; Fan D
    Biochem Cell Biol; 2006 Apr; 84(2):135-41. PubMed ID: 16609693
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T cell receptor Vbeta repertoire expression reflects gastric carcinoma progression.
    Zhang XY; Chan WY; Whitney BM; Fan DM; Chow JH; Liu Y; Ng EK; Chung SC
    Clin Immunol; 2001 Oct; 101(1):3-7. PubMed ID: 11580220
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of secernin 1 as a novel immunotherapy target for gastric cancer using the expression profiles of cDNA microarray.
    Suda T; Tsunoda T; Uchida N; Watanabe T; Hasegawa S; Satoh S; Ohgi S; Furukawa Y; Nakamura Y; Tahara H
    Cancer Sci; 2006 May; 97(5):411-9. PubMed ID: 16630140
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Defective CD3zeta chain expression in Herpesvirus saimiri (HVS)-derived T-cell lines in gastric adenocarcinoma.
    Lopez-Santalla M; Krishnan S; Valeri AP; Aguilera-Montilla N; Fisher CU; Perez-Blas M; Gutierrez-Calvo A; Lasa I; Granell-Vicent J; Tsokos GC; Martin-Villa JM
    Cell Immunol; 2005 Dec; 238(2):113-22. PubMed ID: 16616055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NKG2D-mediated antitumor activity by tumor-infiltrating lymphocytes and antigen-specific T-cell clones isolated from melanoma patients.
    Maccalli C; Nonaka D; Piris A; Pende D; Rivoltini L; Castelli C; Parmiani G
    Clin Cancer Res; 2007 Dec; 13(24):7459-68. PubMed ID: 18094430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural killer cell activity depression in peripheral blood and ascites from gastric cancer patients with high TGF-beta 1 expression.
    Yoon SJ; Heo DS; Kang SH; Lee KH; Kim WS; Kim GP; Lee JA; Lee KS; Bang YJ; Kim NK
    Anticancer Res; 1998; 18(3A):1591-6. PubMed ID: 9673375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Melan-A/MART1 analog peptide triggers anti-myeloma T-cells through crossreactivity with HM1.24.
    Christensen O; Lupu A; Schmidt S; Condomines M; Belle S; Maier A; Hose D; Neuber B; Moos M; Kleist C; Terness P; Ho AD; Goldschmidt H; Klein B; Hundemer M
    J Immunother; 2009; 32(6):613-21. PubMed ID: 19483648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The immunogenicity of the hTERT540-548 peptide in cancer.
    Wenandy L; Sørensen RB; Sengeløv L; Svane IM; thor Straten P; Andersen MH
    Clin Cancer Res; 2008 Jan; 14(1):4-7. PubMed ID: 18172245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The CD4(+) T-cell response of melanoma patients to a MAGE-A3 peptide vaccine involves potential regulatory T cells.
    François V; Ottaviani S; Renkvist N; Stockis J; Schuler G; Thielemans K; Colau D; Marchand M; Boon T; Lucas S; van der Bruggen P
    Cancer Res; 2009 May; 69(10):4335-45. PubMed ID: 19435913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generation of CA125-specific cytotoxic T lymphocytes in human leukocyte antigen-A2.1-positive healthy donors and patients with advanced ovarian cancer.
    Bellone S; Anfossi S; O'Brien TJ; Cannon MJ; Silasi DA; Azodi M; Schwartz PE; Rutherford TJ; Pecorelli S; Santin AD
    Am J Obstet Gynecol; 2009 Jan; 200(1):75.e1-10. PubMed ID: 18976739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Distribution of lymphocyte subpopulation and natural killer activity in gastric cancer tissue, normal stomach and various tissues of gastric cancer patients].
    Moritani Y
    Nihon Geka Gakkai Zasshi; 1984 Feb; 85(2):132-42. PubMed ID: 6611484
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of advanced metastasized breast cancer with bone marrow-derived tumour-reactive memory T cells: a pilot clinical study.
    Schuetz F; Ehlert K; Ge Y; Schneeweiss A; Rom J; Inzkirweli N; Sohn C; Schirrmacher V; Beckhove P
    Cancer Immunol Immunother; 2009 Jun; 58(6):887-900. PubMed ID: 18998129
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The degree of macrophage infiltration into the cancer cell nest is a significant predictor of survival in gastric cancer patients.
    Ohno S; Inagawa H; Dhar DK; Fujii T; Ueda S; Tachibana M; Suzuki N; Inoue M; Soma G; Nagasue N
    Anticancer Res; 2003; 23(6D):5015-22. PubMed ID: 14981961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New peptide vaccine candidates for epithelial cancer patients with HLA-A3 supertype alleles.
    Matsueda S; Takedatsu H; Sasada T; Azuma K; Ishihara Y; Komohara Y; Noguchi M; Shichijo S; Itoh K; Harada M
    J Immunother; 2007 Apr; 30(3):274-81. PubMed ID: 17414318
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dendritic cells engineered to express defined allo-HLA peptide complexes induce antigen-specific cytotoxic T cells efficiently killing tumour cells.
    Stronen E; Abrahamsen IW; Gaudernack G; Wälchli S; Munthe E; Buus S; Johansen FE; Lund-Johansen F; Olweus J
    Scand J Immunol; 2009 Apr; 69(4):319-28. PubMed ID: 19284496
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of a MAGE-1-derived HLA-A24 epitope-specific CTL line from a Japanese metastatic melanoma patient.
    Akiyama Y; Maruyama K; Tai S; Komiyama M; Iizuka A; Takikawa M; Ohshita C; Yamamoto A; Yamazaki N; Kiyohara Y; Yamaguchi K
    Anticancer Res; 2009 Feb; 29(2):647-55. PubMed ID: 19331215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intrinsic defects explain altered proliferative responses of T lymphocytes and HVS-derived T-cell lines in gastric adenocarcinoma.
    Valeri AP; Pérez-Blas M; Gutiérrez A; López-Santalla M; Aguilera N; Rodríguez-Juan C; Sala-Silveira L; Martín J; Lasa I; Mugüerza JM; López A; García-Sancho L; Granell J; Martín-Villa JM
    Cancer Immunol Immunother; 2003 Nov; 52(11):708-14. PubMed ID: 12830324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies.
    Li B; Simmons A; Du T; Lin C; Moskalenko M; Gonzalez-Edick M; VanRoey M; Jooss K
    Clin Immunol; 2009 Nov; 133(2):184-97. PubMed ID: 19664962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-T cell disturbance causes the suppression of the autologous mixed lymphocyte reaction in patients with gastric carcinoma.
    Iwahashi M; Tanimura H; Yamaue H; Tsunoda T; Tani M; Noguchi K; Mizobata S; Tamai M; Hotta T; Arii K
    Anticancer Res; 1995; 15(3):799-804. PubMed ID: 7645961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.